About
Drugs targeting disease-specific GPCR heterodimers
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (9)
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
147
By Phase
PHASE2: 4PHASE1: 1
By Status
COMPLETED: 4ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05561751Lead Sponsor
Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
PHASE2Active, not recruiting
40 participants
Started: Feb 13, 2023 · Completed: Sep 30, 2025
NCT02104427Lead Sponsor
PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
PHASE2Completed
12 participants
Started: Feb 28, 2015 · Completed: Nov 30, 2015
NCT01458288Lead Sponsor
A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease
PHASE2Completed
12 participants
Started: Oct 31, 2012 · Completed: Jul 31, 2013
NCT01018979Lead Sponsor
Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
PHASE2Completed
19 participants
Started: Feb 28, 2010 · Completed: Oct 31, 2011
NCT00822341Lead Sponsor
Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of TG-0054 With Single IV Doses Escalation in Healthy Volunteers
PHASE1Completed
64 participants
Started: Apr 30, 2008 · Completed: May 31, 2009
Locations (1)
Headquarters
Seoul, Korea
Map
Loading map...